First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - New treatments and trials Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by